Transdermal Skin Patches Market is Estimated to Witness High Growth Owing to Rising Prevalence of Chronic Diseases

 

Transdermal Skin Patches Market

The transdermal skin patches market has witnessed significant growth over the past few years owing to growing demand in applications such as pharmaceuticals and medical therapy. Transdermal skin patches are drug delivery systems used to deliver a therapeutically effective amount of medication through the skin and into the bloodstream. They provide several advantages over conventional oral drug delivery methods including controlled release of drugs at predetermined rates, non-invasiveness, and direct access to systemic circulation. Owing to these benefits, transdermal skin patches are widely being used for delivery of nicotine, hormones, analgesics and various other drugs.

The Global transdermal skin patches market is estimated to be valued at US$ 9773.27 Bn in 2024 and is expected to exhibit a CAGR of 23% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the transdermal skin patches are Omsk Carbon Group, Tokai Carbon Co., Ltd., Atlas Organics Private Limited, Continental Carbon Company, Birla Carbon, Cabot Corporation, International China Oak Investment Holdings Co., Ltd., Himadri Speciality Chemical Ltd, Philips Carbon Black Limited, Orion Engineered Carbons GmbH, Ralson.

Key opportunities in the market include growing focus on developing generic transdermal patches and expansion in emerging countries. Pharmaceutical companies are also focusing on development of advanced transdermal patches for delivery of large molecule drugs.

The global expansion of the Transdermal Skin Patches Market Size is mainly driven by the rising prevalence of chronic diseases worldwide. According to the WHO, chronic diseases are the leading cause of mortality in the world, representing 63% of all deaths globally. Growth in the aging population is also fueling the demand for transdermal patches significantly.

Market drivers

The major driver for the growth of transdermal skin patches market is the rising prevalence of chronic diseases including diabetes, hypertension and Alzheimer's disease across the globe. As per the International Diabetes Federation, around 537 million adults were living with diabetes in 2021 worldwide and the number is projected to rise to 643 million by 2030 and 783 million by 2045. Transdermal patches help in effective management of such chronic conditions through controlled and sustained drug delivery. Another key driver is the ability of transdermal patches to provide fast pain relief for acute conditions compared to oral medications. This is increasing their adoption for delivery of analgesics and anesthetics.


PEST Analysis
Political: Regulations regarding drug approvals and clinical trials impact market growth. Favorable regulatory environment and schemes boost R&D activities.

Economic: Rising healthcare expenditure and affordability drive market demand. Expanding middle-class population requiring treatment for chronic ailments fuel market growth.

Social: Growing awareness regarding various skin disorders and availability of advanced treatment options influence market trends. Increasing incidence of chronic pain, neurological disorders, and cardiovascular diseases also contribute to market growth.

Technological: Advanced material science and miniaturization allow development of highly efficient transdermal patches. Focus on patient comfort, delivery, and controlled release propels technological innovations in patch design.

Geographical Regions with High Market Concentration

The transdermal skin patches market in terms of value is highly concentrated in North America and Western Europe. This can be attributed to presence of major pharmaceutical companies, advanced healthcare infrastructure, high awareness regarding therapies, and favorable reimbursement policies supporting market growth in these regions.

Fastest Growing Region


Asia Pacific region is expected to be the fastest growing market for transdermal skin patches during the forecast period. Growth driving factors include rising healthcare spending, presence of generic manufacturers, increasing incidence of chronic diseases, growing geriatric population, expanding distribution channels, and favorable government initiatives supporting healthcare sector development in emerging Asian countries.

About Author:

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)


Comments

Popular posts from this blog

Power Management ICs - Enabling Next Generation Power Efficient Electronics

Colposcope: A Valuable Tool for Women's Health

Blood Based Biomarker: The Future of Non-Invasive Disease Diagnosis and Treatment